Immunovant Inc (IMVT)
Healthcare
Biotechnology
38.50 $
-0.3%
vs. previous close
Closing price · As of: 3. Aug 2026
Immunovant Inc (IMVT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -95 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -47 | -60 | -47 | -60 | -76 | -89 | -100 | -111 | -117 | -103 | -92 | -95 | -407 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | |
| 11 | 11 | 10 | 9.7 | 13 | 13 | 12 | 12 | 19 | 13 | 13 | 11 | 56 | |
| 11 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 16 | -12 | -6.3 | 5.6 | -2.7 | 7.7 | -1.0 | -16 | -15 | 11 | 5.5 | 42 | 42 | |
| 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | -0.1 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | – | – | – | 0.0 | – | |
| 0.9 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.9 | 0.1 | 470 | 1.5 | 0.7 | 0.7 | 2.5 | 451 | 2.9 | 25 | 565 | 3.6 | 596 | |
| -47 | -60 | 421 | -56 | -75 | -87 | -98 | 339 | -115 | -77 | 473 | -92 | 188 | |
| -47 | -60 | -47 | -60 | -76 | -89 | -101 | -111 | -117 | -103 | -92 | -95 | -407 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.